Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Charles Y. Lin et al.|Nature|2016Cited by 629
Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast ActivationMatthew S. Stratton, Timothy A. McKinsey, Rushita A. Bagchi et al.|Circulation Research|2019Cited by 177
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Yanhua Zhao et al.|Cancer Discovery|2021Cited by 90
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Thomas F. Westbrook, Hsiang-Ching Chung et al.|Nature Medicine|2018Cited by 83
IRF2 is a master regulator of human keratinocyte stem cell fateNicolas Mercado, Susan C. Kirkland, Gabi Schutzius et al.|Nature Communications|2019Cited by 38